Dirk Fischer

University of Basel — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

43h-index5.8kcitations191works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Muscle Physiology and Disorders(70), Neurogenetic and Muscular Disorders Research(34), Genetic Neurodegenerative Diseases(30), Cardiomyopathy and Myosin Studies(24), RNA Research and Splicing(13)

Publications189 total

Beyond Hotspots: Advanced Geospatial Strategies for Understanding Intrapersonal Violence
Journal of Forensic Nursing·2025
Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy
Redox Biology·2025· 3 citedOpen Access
Säugling mit Rechtsherzversagen und hochgradigen Rhythmusstörungen: Neue Missense-Mutation im ATRX-Gen
Zeitschrift für Geburtshilfe und Neonatologie·2025
Automated analysis of quantitative muscle MRI and its reliability in patients with Duchenne muscular dystrophy
Journal of Neuromuscular Diseases·2025Open Access
A Hypothesized Therapeutic Role of (Z)-Endoxifen in Duchenne Muscular Dystrophy (DMD)
Degenerative Neurological and Neuromuscular Disease·2025Open Access
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double–blind, placebo–controlled, phase 3 trial (TAMDMD Group B)
Neuromuscular Disorders·2025· 4 citedOpen Access
401P Moderate-term dimethyl fumarate treatment reduces fibrosis of skeletal and cardiac muscle in in the mdx mouse model of Duchenne muscular dystrophy
Neuromuscular Disorders·2024
Moderate-term dimethyl fumarate treatment reduces pathology of dystrophic skeletal and cardiac muscle in a mouse model
2024· 1 cited
Dimethyl fumarate modulates the dystrophic disease program following short-term treatment
JCI Insight·2023· 12 citedOpen Access
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Neurology·2023· 22 citedOpen Access
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study
Neurology and Therapy·2023· 1 citedOpen Access
Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial
Frontiers in Pharmacology·2023· 2 citedOpen Access
Cervical Spinal Cord Gray Matter Atrophy as an Emerging Imaging Marker in Spinal Muscular Atrophy (P2-8.014)
Neurology·2023
Cervical Spinal Cord Gray Matter Area is Associated with Motor Unit Number Index in Spinal Muscular Atrophy (S33.008)
Neurology·2023
JEWELFISH: 24-month Safety, Pharmacodynamic and Exploratory Efficacy Data in Non-Treatment-Naïve Patients with Spinal Muscular Atrophy (SMA) Receiving Treatment with Risdiplam (P7-9.004)
Neurology·2023
Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers
Scientific Reports·2023· 9 citedOpen Access
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study
Neurology and Therapy·2023· 52 citedOpen Access
The Phenomenon of Allocation: Military Pathways in the Light of Biomedical Ethical Principles
Military and humanitarian health ethics·2023
Dimethyl fumarate modulates the Duchenne muscular dystrophy disease program following short-term treatment in <i>mdx</i> mice
2022· 1 citedOpen Access
185 JEWELFISH: Safety, pharmacodynamic and exploratory efficacy data in non-naïve patients with SMA receiving risdiplam
Journal of Neurology Neurosurgery & Psychiatry·2022
page 1 of 10Next →

Frequent Co-authors

Patricia Hafner(10), Oliver Bieri(10), M Gloor(9), Rolf Schröder(8), Arne Fischmann(8), Matthias Vorgerd(7), Leo H. Bonati(7), Hanns Lochmüller(6), Tanja Haas(6), Nuri Gueven(6), Maggie C. Walter(5), Rudolf A. Kley(4), Angela Huebner(4), Lev G. Goldfarb(4), Maurice Schmid(4), Andrea Klein(4), Daniela Rubino(4), Katharina Strach(3), Jens Reimann(3), Montse Olivé(3)